Intersect ENT’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Intersect ENT designs, manufactures, and distributes medical devices for the treatment of chronic sinusitis. Read more

Thomas A. West's photo - President & CEO of Intersect ENT

President & CEO

Thomas A. West

CEO Approval Rating

87/100

Founded:

2003

Status:

PublicNASDAQXENT

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Medtronic is one of Intersect ENT's top rivals. Medtronic was founded in Minneapolis, Minnesota} in 1949. Like Intersect ENT, Medtronic also competes in the Health Care Equipment space. Compared to Intersect ENT, Medtronic generates $27.8B more revenue.

Olympus is Intersect ENT's #2 competitor. Olympus was founded in 1919, and is headquartered in Shinjuku-ku, Tōkyō Prefecture. Like Intersect ENT, Olympus also operates in the Health Care Equipment space. Olympus generates $7B more revenue vs. Intersect ENT.

Johnson & Johnson is a top competitor of Intersect ENT. Johnson & Johnson's headquarters is in New Brunswick, New Jersey, and was founded in 1886. Johnson & Johnson is in the Health Care Supplies industry. Johnson & Johnson generates 94,206% of Intersect ENT's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is SinuSys a competitor of Intersect ENT?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$85.4M

Intersect ENT's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 14.5B. Over the last four quarters, Intersect ENT's revenue has decreased by 59.3%. Specifically, in Q2 2020's revenue was $9.8M; in Q1 2020, it was $19.8M; in Q4 2019, it was $31.8M; in Q3 2019, Intersect ENT's revenue was $24.1M.

Acquisitions

No recent acquisitions found related to Intersect ENT

Intersect ENT Funding History

$30M$31M$86M$151M

Since Intersect ENT was founded in 2003, it has participated in 4 rounds of funding. In total Intersect ENT has raised $151.0M. Intersect ENT's last funding round was on May 2020 for a total of $65.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Convertible Note
May 2020
$65M

Deerfield Management

IPO
Jul 2014
$55M
-
Series C
Sep 2011
$1M
-
Series B
Oct 2010
$30M

Total Funding: $151M

Since Intersect ENT was founded in 2003, it has participated in 4 rounds of funding. In total Intersect ENT has raised $151.0M. Intersect ENT's last funding round was on May 2020 for a total of $65.0M

Investments

No recent investments found related to Intersect ENT

Intersect ENT News

May 11, 2020MarketScreener

Announces $65 Million Convertible Notes Investment from Deerfield Management

(marketscreener.com) Intersect ENT, Inc. , a company transforming care for patients with ear, nose an... See more »
May 8, 2020MarketScreener

to Present at the 2020 Bank of America Merrill Lynch Global Healthcare Conference

Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in a virtual fir... See more »
May 2, 2020ForexTV

Did You Acquire XENT Before August 1, 2018? Johnson Fistel Continues its Investigation of Intersect ENT, Inc.; Should Management be Held Accountable for Investors Losses?

SAN DIEGO, May 02, 2020 (GLOBE NEWSWIRE) - Johnson Fistel, LLP is investigating potential claims on b... See more »
April 15, 2020Zacks

Intersect Posts Preliminary Q1 Results, Withdraws '20 View

Intersect (XENT) expects the impact of the coronavirus pandemic to substantially dampen revenues in t... See more »
March 18, 2020Benzinga

Johnson Fistel Investigates Intersect ENT, Inc.; Should Management be Held Accountable for Investors Losses?

SAN DIEGO, March 18, 2020 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential claims o... See more »

Intersect ENT Press Releases

July 4, 2019Law.com

Class Action Filed Against Intersect ENT, Inc. - Kehoe Law Firm, P.C. Investigating Claims on Behalf of XENT Shareholders

Kehoe Law Firm, P.C. is investigating claims on behalf of shareholders of Intersect ENT, Inc. A shar... See more »
June 18, 2019GlobalNewswire

Bernstein Liebhard LLP Announces That Four Weeks Remain to Make a Motion For Lead Plaintiff In a Class Action Against Intersect ENT - XENT

NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor r... See more »
April 25, 2019Business Wire

Intersect ENT to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT) today announced that manageme... See more »
December 17, 2018StreetInsider

Intersect ENT Announces First Patient Enrolled in ASCEND Study of Investigational Drug-Coated Sinus Balloon

Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, n... See more »
December 11, 2018StreetInsider

Intersect ENT to Present at the 37th Annual J.P. Morgan Healthcare Conference

Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 37th Annu... See more »
May 1, 2018StreetInsider

Intersect ENT Reports First Quarter 2018 Results

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to impr... See more »
April 17, 2018Business Wire

Intersect ENT to Present at Deutsche Bank and Bank of America Merrill Lynch Conferences

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT) today announced that manageme... See more »

Intersect ENT Videos

Social Statistics

Headquarters

1555 Adams Drive

Menlo Park, California94025

650-641-2100

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Intersect ENT designs, manufactures, and distributes medical devices for the treatment of chronic sinusitis. Intersect ENT was founded in 2003. Intersect ENT's headquarters is located in Menlo Park, California, USA 94025. It has raised 151.0M in 4 rou...

CEO

Intersect ENT's President & CEO, Thomas A. West, currently has an approval rating of 87%. Intersect ENT's primary competitors are Medtronic, Olympus & Johnson & Johnson.

Website

intersectent.com

Frequently Asked Questions about Intersect ENT

  1. When was Intersect ENT founded?

    Intersect ENT was founded in 2003
  2. Who is Intersect ENT's CEO?

    Intersect ENT's CEO is Thomas A. West
  3. How much revenue does Intersect ENT generate?

    Intersect ENT generates $85.4M in revenue
  4. How much funding does Intersect ENT have?

    Intersect ENT has historically raised $151M in funding
  1. Where is Intersect ENT's headquarters?

    Intersect ENT's headquarters is in Menlo Park California, USA
  2. How many employees does Intersect ENT have?

    Intersect ENT has 393 employees
  3. What sector does Intersect ENT operate in?

    Intersect ENT is in Health Care Equipment
  4. Who are Intersect ENT's competitors?

    Intersect ENT's top competitors are Medtronic, Olympus, Johnson & Johnson